Akums Drugs and Pharmaceuticals Limited — Board Meeting, 06-02-2025: Outcome of Board Meeting

The Board of Akums Drugs and Pharmaceuticals has approved the unaudited financial results for the quarter and nine months ended December 31, 2024, reporting total income of approximately ₹371.25 Cr, and a profit of about ₹41.17 Cr for the period. The Board also acknowledged the retirement of Independent Director Mr. Nand Lal Kalra and outlined changes in committee compositions. Significant investments were approved, including establishing subsidiaries in the UK and Malta to boost export business and setting up an R&D division in Mumbai with an estimated cost of ₹27 Cr. Additionally, postal ballot notices were approved for the modification of the Employee Stock Option Scheme.